‘Manipulation of Immune Checkpoints via an Epitope-Specific Vaccine Restores Immune Tolerance and Induces Clinical Amelioration in Human Rheumatoid Arthritis’ (W.75)
Presented by Sherlynn Chan of the Albani-lab (Translational Immunology Institute/Singapore Health Services). Thankful to be part of this collaboration.
Wednesday June 20, 6:15 PM – 7:30 PM, at FOCIS 2018.
‘Reactivation of immune checkpoints by an epitope-specific vaccine reinstates tolerogenic pathways and induces clinical amelioration in patients with rheumatoid arthritis.’
Poster presentation on the 16th of June at 10:30 (SAT0232) by the Albani lab.
View the abstract
Website EULAR 2018, in Amsterdam
Excited to see our opinion article in The Scientist discussing the increased heterogeneity within naive T cells and the implications it could have for vaccine strategies, among others.
Review in Nat Rev Imm and the Marie Curie grant highlighted in the Child Health newsletter of University Medical Center Utrecht!
Mentioned in the Laboratory of Translational Immunology newsletter for receiving a Marie-Curie individual fellowship!
Our review is trending on twitter and retweeted by Michael McHeyzer-Williams, among others. Keep sharing and thanks for all the retweets.
Our review on the unrecognized heterogeneity within the human naive T cell compartment is now online, Nature Reviews Immunology!
With Femke van Wijk and José Borghans
The full spectrum of human naive T cells. (PMID:29520044)
Awarded a Marie Curie global individual 3-year fellowship!
(H2020-MSCA-IF-GF-2017)
Project: Regulation of B-cell Epitope migration and Autoimmunity by T follicular helper cells (BEAT) at Harvard Medical School/Boston Children’s Hospital, Boston, MA, USA. M.C. Carroll lab.
I will keep you updated on my Marie Curie experience.
